These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7623499)

  • 21. Toxic psychosis from transdermal scopolamine in a child.
    Sennhauser FH; Schwarz HP
    Lancet; 1986 Nov; 2(8514):1033. PubMed ID: 2877187
    [No Abstract]   [Full Text] [Related]  

  • 22. [A draftee got a CNS disorder after treatment with scopolamine plaster].
    Olevik P
    Lakartidningen; 1987 Apr; 84(17):1463. PubMed ID: 3586788
    [No Abstract]   [Full Text] [Related]  

  • 23. Unilateral mydriasis caused by transdermal scopolamine.
    Rubin MM; Sadoff RS; Cozzi GM
    Oral Surg Oral Med Oral Pathol; 1990 Nov; 70(5):569-70. PubMed ID: 2234876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute pupil asymmetry in a 6-month-old boy. Diagnosis: pharmacologic anisocoria.
    Osorio MJ; Zuckerbraun NS; Painter M
    Pediatr Ann; 2009 Nov; 38(11):622-4, 627. PubMed ID: 19968207
    [No Abstract]   [Full Text] [Related]  

  • 25. Side effects of transdermal scopolamine.
    Wilkinson JA
    J Emerg Med; 1987; 5(5):389-92. PubMed ID: 3668203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 27. Preoperative anisocoria from a scopolamine patch.
    Rosenberg M
    Anesth Analg; 1987 Jul; 66(7):693. PubMed ID: 3605683
    [No Abstract]   [Full Text] [Related]  

  • 28. [Unusual cases of anisocoria--report of two cases].
    Jankowska-Folusiak J; Barwina M; Sein Anand J
    Przegl Lek; 2011; 68(8):553-4. PubMed ID: 22010465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity to scopolamine in transdermal therapeutic systems.
    van der Willigen AH; Oranje AP; Stolz E; van Joost T
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):146-7. PubMed ID: 3346401
    [No Abstract]   [Full Text] [Related]  

  • 30. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
    Harnett MJ; O'Rourke N; Walsh M; Carabuena JM; Segal S
    Anesth Analg; 2007 Sep; 105(3):764-9. PubMed ID: 17717237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scopolamine skin-disks and anisocoria.
    Bienia RA; Smith M; Pellegrino T
    Ann Intern Med; 1983 Oct; 99(4):572-3. PubMed ID: 6625403
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical manifestations of transdermal scopolamine addiction.
    Luetje CM; Wooten J
    Ear Nose Throat J; 1996 Apr; 75(4):210-4. PubMed ID: 8935644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal scopolamine use in the control of narcotic-induced nausea.
    Ferris FD; Kerr IG; Sone M; Marcuzzi M
    J Pain Symptom Manage; 1991 Aug; 6(6):389-93. PubMed ID: 1880439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not your everyday anisocoria: angel's trumpet ocular toxicity.
    Firestone D; Sloane C
    J Emerg Med; 2007 Jul; 33(1):21-4. PubMed ID: 17630070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anisocoria and topical carbamate exposure: illustrative case report.
    Upshaw J; MacLean B; Losek JD
    Clin Pediatr (Phila); 2010 May; 49(5):502-5. PubMed ID: 20118074
    [No Abstract]   [Full Text] [Related]  

  • 38. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine withdrawal syndrome.
    Saxena K; Saxena S
    Postgrad Med; 1990 Jan; 87(1):63-6. PubMed ID: 2296571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No causal relationship between transdermal scopolamine and seizures: methodologic lessons for pharmacoepidemiology.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M; Waiter SL
    Clin Pharmacol Ther; 1991 Jul; 50(1):107-13. PubMed ID: 1855348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.